glp-1 off label use Managing Side Effects and Dosing in Off-Label with Help from Real-World Evidence Specialty Physicians on Using GLP-1

Clinical studies have shown that oral semaglutide can lead to significant weight loss for people who are overweight or obese

Patients should contact their healthcare provider if they experience recurrent dizziness or lightheadedness that interferes with daily activities, particularly if symptoms persist beyond the first few weeks of therapy or occur with each dose increase

Fat metabolism & lipolysis Studied in preclinical adipocyte research as an NNMT inhibitor exploring fat breakdown and cellular energy expenditure

Glp-1 (Glucagon Like Peptide) Single molecule made in the small intestine and colon Causes the pancreas to make insulin when sugar is in the blood stream, in a dose dependent fashion (the more sugar you have, the more GLP-1 tells the pancreas to release insulin) Tells the gastrointestinal tract to slow down digestion Slows down carbohydrate absorption (so your blood sugar doesnt escalate quickly) Curbs appetite Animal studies show GLP-1 may promote regeneration of the beta cells in the pancreas by fighting programmed cell death (apoptosis)